📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Trimeris

1.1 - Company Overview

Trimeris Logo

Trimeris

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of HIV research and drug discovery, founded in 1993 in Morrisville, North Carolina, whose early work led to an entirely new class of anti-HIV drugs called fusion inhibitors.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Trimeris

Biocure Technology Logo

Biocure Technology

HQ: Canada Website
  • Description: Provider of biosimilars and CAR-T cell pharmaceutical products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biocure Technology company profile →
Eiger BioPharmaceuticals Logo

Eiger BioPharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies, including lonafarnib, an oral farnesyl-transferase inhibitor blocking Hepatitis Delta Virus replication; avexitide, a GLP-1 receptor antagonist for post-bariatric hypoglycemia and congenital hyperinsulinism; Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and processing-deficient Progeroid Laminopathies; and an Expanded Access Program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eiger BioPharmaceuticals company profile →
Ciclofilin Pharmaceuticals Logo

Ciclofilin Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development focused on cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and degenerative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ciclofilin Pharmaceuticals company profile →
Bugworks Research Logo

Bugworks Research

HQ: India Website
  • Description: Provider of drug discovery focused on combating antimicrobial resistance (AMR) and small molecule cancer therapeutics, including BWC2094 targeting the adenosine pathway (CRC, NSCLC, TNBC, pancreas, prostate, RCC, HNSCC); ATM/DNA-PK dual inhibitors (BWC5036/BWC5089); BWC5044/BWC5077, BWC4496; spliceosome modulators/DNA damage agents; and ADC payload opportunities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bugworks Research company profile →
Elion Therapeutics Logo

Elion Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology solutions focused on treating life-threatening IFIs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elion Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Trimeris

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Trimeris

2.2 - Growth funds investing in similar companies to Trimeris

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Trimeris

4.2 - Public trading comparable groups for Trimeris

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Trimeris

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Trimeris

What does Trimeris do?

Trimeris is a provider of HIV research and drug discovery, founded in 1993 in Morrisville, North Carolina, whose early work led to an entirely new class of anti-HIV drugs called fusion inhibitors.

Who are Trimeris's competitors?

Trimeris's competitors and similar companies include Biocure Technology, Eiger BioPharmaceuticals, Ciclofilin Pharmaceuticals, Bugworks Research, and Elion Therapeutics.

Where is Trimeris headquartered?

Trimeris is headquartered in United States.

How many employees does Trimeris have?

Trimeris has 1,000 employees 🔒.

When was Trimeris founded?

Trimeris was founded in 2010 🔒.

What sector and industry vertical is Trimeris in?

Trimeris is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Trimeris

Who are the top strategic acquirers in Trimeris's sector and industry

Top strategic M&A buyers and acquirers in Trimeris's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Trimeris?

Top strategic M&A buyers groups and sectors for Trimeris include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Trimeris's sector and industry vertical

Which are the top PE firms investing in Trimeris's sector and industry vertical?

Top PE firms investing in Trimeris's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Trimeris's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Trimeris's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Trimeris's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Trimeris include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Trimeris's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Trimeris?

The key public trading comparables and valuation benchmarks for Trimeris include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Trimeris for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Trimeris with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Trimeris's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Trimeris with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Trimeris's' sector and industry vertical?

Access recent funding rounds and capital raises in Trimeris's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Trimeris

Launch login modal Launch register modal